Ahmad, M., Vasdev, N., Thorpe, A., & Whiteway, J. (2012). 776 Is concomitant carcinoma in situ a relative contraindication to neoadjuvant chemotherapy for muscle invasive TCC bladder? European Urology Supplements, 11(1), e776. https://doi.org/10.1016/S1569-9056(12)60773-8
Chicago Style (17th ed.) CitationAhmad, M.S, N. Vasdev, A.C Thorpe, and J. Whiteway. "776 Is Concomitant Carcinoma in Situ a Relative Contraindication to Neoadjuvant Chemotherapy for Muscle Invasive TCC Bladder?" European Urology Supplements 11, no. 1 (2012): e776. https://doi.org/10.1016/S1569-9056(12)60773-8.
MLA (9th ed.) CitationAhmad, M.S, et al. "776 Is Concomitant Carcinoma in Situ a Relative Contraindication to Neoadjuvant Chemotherapy for Muscle Invasive TCC Bladder?" European Urology Supplements, vol. 11, no. 1, 2012, p. e776, https://doi.org/10.1016/S1569-9056(12)60773-8.